SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-20-019252
Filing Date
2020-10-13
Accepted
2020-10-09 17:31:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13d.htm SC 13D 177869
2 ex99-1.htm EX-99.1 22802
  Complete submission text file 0001493152-20-019252.txt   201906
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Subject) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91738 | Film No.: 201234045
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3992 BLUEBONNET DR., BUILDING 14 STAFFORD TX 77477
Business Address
Patel Kinnary (Filed by) CIK: 0001828008 (see all company filings)

Type: SC 13D